Skip to main content
. Author manuscript; available in PMC: 2006 Sep 28.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2006 Jan;47(1):151–157. doi: 10.1167/iovs.05-0351

Figure 2.

Figure 2

Inhibition of epithelial outgrowth by LY294002 and SR13668. Epithelial outgrowth was dose-dependently inhibited by LY294002, an inhibitor of PI3K, from 5 to 50 μM (A). Compared with the control, complete inhibition of epithelial outgrowth was noted at 20 (not shown) and 50 μM of LY294002 (B). The addition of 10 μM SR13668, a phosphor-Akt inhibitor, partially suppressed the outgrowth (C), but 50 μM of SR13668 completely abolished the outgrowth (D).